Literature DB >> 16939854

Role of viral infections in the etiology of febrile seizures.

J Gordon Millichap1, John J Millichap.   

Abstract

The role of viral infection in the etiology of febrile seizures is a relatively neglected field of neurologic research. A National Institutes of Health Consensus Conference (1981) omitted reference to causes of infections and the role of fever in febrile seizures, and emphasized outcome and anticonvulsant treatment. In an earlier review of the world literature (1924-1964), except for roseola infantum, viral infections as a cause of febrile seizures were rarely diagnosed. The present review includes reports of viruses most commonly associated with febrile seizures in the last decade, especially human herpesvirus-6 and influenza. The specificity and neurotropic properties of some viruses in the febrile seizure mechanism, a possible encephalitic or encephalopathic pathology, and the essential role of fever and height of the body temperature as a measure of the febrile seizure threshold are discussed. Cytokine and immune response to infection, and a genetic susceptibility to febrile seizures are additional etiologic factors. Future research should emphasize early detection of causative viruses, the nature of viral neurotropism, and the role of cytokines in fever induction. Trials of antiviral agents and vaccines, with attention to safety concerns, and more effective antipyretics would address the febrile seizure mechanism more specifically than anticonvulsant therapies.

Entities:  

Mesh:

Year:  2006        PMID: 16939854     DOI: 10.1016/j.pediatrneurol.2006.06.004

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  31 in total

1.  Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Future Virol       Date:  2011-11       Impact factor: 1.831

2.  The U24 protein from human herpesvirus 6 and 7 affects endocytic recycling.

Authors:  Brian M Sullivan; Laurent Coscoy
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

3. 

Authors:  Nicholas Monfries; Ran D Goldman
Journal:  Can Fam Physician       Date:  2017-02       Impact factor: 3.275

4.  Altered synaptic transmission in the hippocampus of transgenic mice with enhanced central nervous systems expression of interleukin-6.

Authors:  T E Nelson; A Olde Engberink; R Hernandez; A Puro; S Huitron-Resendiz; C Hao; P N E De Graan; D L Gruol
Journal:  Brain Behav Immun       Date:  2012-05-17       Impact factor: 7.217

Review 5.  Clinical impact of primary infection with roseoloviruses.

Authors:  Brenda L Tesini; Leon G Epstein; Mary T Caserta
Journal:  Curr Opin Virol       Date:  2014-10-14       Impact factor: 7.090

6.  Prophylactic antipyretics for prevention of febrile seizures following vaccination.

Authors:  Nicholas Monfries; Ran D Goldman
Journal:  Can Fam Physician       Date:  2017-02       Impact factor: 3.275

7.  Gene expression analysis in children with complex seizures due to influenza A(H1N1)pdm09 or rotavirus gastroenteritis.

Authors:  Mitsuru Tsuge; Takashi Oka; Nobuko Yamashita; Yukie Saito; Yosuke Fujii; Yoshiharu Nagaoka; Masato Yashiro; Hirokazu Tsukahara; Tsuneo Morishima
Journal:  J Neurovirol       Date:  2014-01-24       Impact factor: 2.643

8.  Registry-based surveillance of influenza-associated hospitalisations during the 2009 influenza pandemic in Denmark: the hidden burden on the young.

Authors:  Katarina Widgren; Jens Nielsen; Kåre Mølbak
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

Review 9.  Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation.

Authors:  Anthony L Komaroff; Philip E Pellett; Steven Jacobson
Journal:  Clin Microbiol Rev       Date:  2020-11-11       Impact factor: 26.132

10.  Natural history of temporal lobe epilepsy: antecedents and progression.

Authors:  Garima Shukla; Asuri N Prasad
Journal:  Epilepsy Res Treat       Date:  2012-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.